Semaglutide

Description

Semaglutide is a glucagon-like peptide-1 (GLP-1) analog with a prolonged half-life, making it a subject of significant research interest in metabolic studies. Its primary mechanism involves binding to and activating the GLP-1 receptor, which plays a crucial role in insulin secretion, glucagon suppression, and gastric emptying. In research models, it is noted for promoting feelings of satiety. This peptide is provided strictly for in-vitro and laboratory research applications into metabolic pathways and receptor interactions.